Skip to main content
Springer logoLink to Springer
. 2022 Apr 12;49(7):2454. doi: 10.1007/s00259-022-05798-6

Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing

Laura Mancini 1,2,, Stefano Casagranda 3, Guillaume Gautier 3, Philippe Peter 3, Bruno Lopez 3, Lewis Thorne 4, Andrew McEvoy 4, Anna Miserocchi 4, George Samandouras 4, Neil Kitchen 4, Sebastian Brandner 5,6, Enrico De Vita 1,2, Francisco Torrealdea 7, Marilena Rega 7, Benjamin Schmitt 8, Patrick Liebig 8, Eser Sanverdi 1,2, Xavier Golay 1,2, Sotirios Bisdas 1,2
PMCID: PMC9165277  PMID: 35412055

Correction to: Eur J Nucl Med Mol Imaging

https://doi.org/10.1007/s00259-022-05676-1

The authors regret that the version of Figure 3 that appears in the original article is incorrect.

The original article has been corrected.

Footnotes

This article is part of the Topical Collection on Erratum

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from European Journal of Nuclear Medicine and Molecular Imaging are provided here courtesy of Springer

RESOURCES